Our Investors

Established in 2010, LNC Therapeutics has already raised €22.7M.

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed LNC, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.


To achieve our ambitious strategy to become a leading biotech company in the development of microbiome-based therapies, we are open to welcome new investors in our portfolio.

Want to talk to our CEO?

Microbiome & us
Mar 12, 2020
LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial | By finalizing the...
> more
Jan 13, 2020
We are looking for Clinical Project Manager | WHAT WE OFFER An exciting opportunity to dive in and begin your career...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
Oct 28, 2019
Jillian L. Waters, Ruth E. Ley The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging...
> more
now on twitter
LNC Therapeutics

Do you have some extra #ReadingTime? Find out more about how this new study discovered tissue bacterial signatures…

LNC Therapeutics © 2020 - all rights reserved terms and conditions